Company Filing History:
Years Active: 2018
Title: **Karim Benihoud: A Pioneer in Adenovirus Vaccine Development**
Introduction
Karim Benihoud is a notable inventor based in Paris, France, recognized for his contribution to the field of vaccine development. His innovative work focuses on the use of recombinant adenoviruses, a promising avenue in modern immunology.
Latest Patents
Karim holds one patent, which revolves around adenovirus vaccine vectors. This invention pertains to recombinant adenoviruses that display one or more heterologous epitope(s) on their fiber protein. These recombinant adenoviruses are crucial for generating an immune response in individuals who possess pre-existing anti-Ad immunity, a significant hurdle in vaccine efficacy.
Career Highlights
Karim is affiliated with the esteemed Institut Gustave Roussy, where he applies his expertise in the development of advanced vaccine technologies. His work plays a vital role in the ongoing efforts to enhance vaccine effectiveness against various diseases.
Collaborations
Throughout his career, Karim has collaborated with notable colleagues such as Anastasia Lanzi and Michel Perricaudet. These partnerships have been instrumental in driving innovative research and developing effective therapeutic solutions in the field of immunology.
Conclusion
Karim Benihoud's contributions to the realm of recombinant adenovirus vaccine technology mark him as a significant figure in the field. His research not only enhances our understanding of immune responses but also paves the way for more effective vaccination strategies. The work being conducted at Institut Gustave Roussy, along with collaborations with other experts, continues to inspire advancements in public health and immunology.